Westfield Capital Management CO LP Dexcom Inc Transaction History

Westfield Capital Management CO LP

$21.2 Billion
Q3 2024

A detailed history of Westfield Capital Management CO LP transactions in Dexcom Inc stock. As of the latest transaction made, Westfield Capital Management CO LP holds 2,842,057 shares of DXCM stock, worth $215 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

2,842,057

Previous 1,965,318 44.61%

Holding current value

$215 Million

Previous $223 Million 14.52%

% of portfolio

0.9%

Previous 1.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $56.1 Million - $102 Million	876,739 Added 44.61%	2,842,057 $190 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $47 Million - $59.8 Million	425,857 Added 27.66%	1,965,318 $223 Million
Q1 2024 May 10, 2024	SELL	$114.22 - $140.1 $36.3 Million - $44.5 Million	-317,825 Reduced 17.11%	1,539,461 $214 Million
Q4 2023 Feb 09, 2024	BUY	$75.49 - $124.16 $711,191 - $1.17 Million	9,421 Added 0.51%	1,857,286 $230 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $70.3 Million - $113 Million	817,351 Added 79.31%	1,847,865 $172 Million
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $60.7 Million - $70.7 Million	-539,981 Reduced 34.38%	1,030,514 $132 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $5.41 Million - $6.4 Million	52,048 Added 3.43%	1,570,495 $182 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $32 Million - $46.3 Million	-377,132 Reduced 19.9%	1,518,447 $172 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $1.26 Million - $1.55 Million	16,470 Added 0.88%	1,895,579 $153 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $100 Million - $196 Million	1,473,288 Added 363.04%	1,879,109 $140 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $17.4 Million - $24.1 Million	185,397 Added 84.11%	405,821 $208 Million
Q4 2021 Feb 10, 2022	BUY	$129.87 - $162.82 $13.2 Million - $16.6 Million	101,770 Added 85.77%	220,424 $118 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $8.28 Million - $11.1 Million	-77,580 Reduced 39.53%	118,654 $64.9 Million
Q2 2021 Aug 10, 2021	SELL	$80.99 - $107.93 $5.48 Million - $7.31 Million	-67,716 Reduced 25.65%	196,234 $83.8 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $8.3 Million - $10.3 Million	97,946 Added 59.0%	263,950 $94.9 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $196,092 - $262,713	-2,514 Reduced 1.49%	166,004 $61.4 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $918,806 - $1.09 Million	9,620 Added 6.05%	168,518 $69.5 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $21.5 Million - $36.1 Million	-342,889 Reduced 68.33%	158,898 $64.4 Million
Q1 2020 May 14, 2020	SELL	$47.79 - $75.63 $5.27 Million - $8.34 Million	-110,337 Reduced 18.03%	501,787 $135 Million
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $1.12 Million - $1.76 Million	30,671 Added 5.27%	612,124 $134 Million
Q3 2019 Nov 08, 2019	BUY	$35.53 - $43.8 $11.9 Million - $14.7 Million	334,773 Added 135.71%	581,453 $86.8 Million
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $2.16 Million - $3.02 Million	77,572 Added 45.87%	246,680 $37 Million
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $3.87 Million - $5.26 Million	-137,830 Reduced 44.9%	169,108 $20.1 Million
Q4 2018 Feb 08, 2019	BUY	$26.99 - $37.37 $4.57 Million - $6.32 Million	169,146 Added 122.75%	306,938 $36.8 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $3.22 Million - $5.06 Million	137,792 New	137,792 $19.7 Million
Q4 2017 Feb 13, 2018	SELL	$11.12 - $15.38 $5.54 Million - $7.67 Million	-498,450 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $5.66 Million - $9.46 Million	498,450	498,450 $24.4 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Account

Westfield Capital Management CO LP Dexcom Inc Transaction History